Mechanisms of PFAS Ototoxicity
The inner ear is highly sensitive to toxic insults due to its limited regenerative capacity and high metabolic demands. PFAS compounds have been shown in animal studies to accumulate in cochlear tissue and damage outer hair cells — the sensory cells responsible for amplifying sound. PFAS-induced oxidative stress and mitochondrial dysfunction in these cells reduces their ability to transduce sound vibrations into neural signals.
Additionally, PFAS may affect the stria vascularis, the structure responsible for maintaining the specialized ionic environment of the inner ear (endolymph). Disruption of endolymph composition impairs auditory transduction and can cause tinnitus and hearing loss.
Human Studies on PFAS and Auditory Function
A study of children aged 5–11 from the NHANES cohort found that higher PFAS blood levels were associated with increased rates of unilateral low-frequency hearing loss. The association was consistent across multiple PFAS compounds and persisted after adjustment for noise exposure, otitis media history, and socioeconomic factors.
Adult studies have found similar associations, with PFOS and PFOA showing the most consistent links to audiometric abnormalities. Occupationally exposed workers near PFAS manufacturing facilities show elevated rates of audiometric notches consistent with cochlear damage.
Clinical Implications
Audiologists and otolaryngologists treating patients with unexplained hearing loss — particularly in younger individuals without noise exposure history — may benefit from including PFAS exposure assessment in their evaluations. Environmental history taking is increasingly recognized as important in audiological practice.
Reducing PFAS exposure through water filtration is among the most actionable preventive measures available. For children in PFAS-contaminated areas, early audiological screening can detect subclinical hearing deficits that benefit from early intervention.